MG
GMED icon

Michael Gelband’s Globus Medical GMED Stock Holding History

Michael Gelband’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-208,902
Closed -$18M – 1751
2026
Q1 		$18M Buy
+208,902
New +$18.8M 0.14% 118
2025
Q4 		– Sell
-78,119
Closed -$4.47M – 1727
2025
Q3 		$4.47M Buy
+78,119
New +$4.5M 0.05% 455
2025
Q1 		– Sell
-173,766
Closed -$14.4M – 1666
2024
Q4 		$14.4M Sell
173,766
-393,152
-69% -$31M 0.1% 189
2024
Q3 		$40.6M Buy
566,918
+201,884
+55% +$14.3M 0.25% 58
2024
Q2 		$25M Buy
+365,034
New +$21.8M 0.17% 98
2023
Q4 		– Sell
-198,480
Closed -$9.86M – 1685
2023
Q3 		$9.86M Buy
198,480
+40,104
+25% +$2.24M 0.09% 230
2023
Q2 		$9.43M Sell
158,376
-9,109
-5% -$519K 0.08% 267
2023
Q1 		$9.49M Buy
167,485
+147,552
+740% +$9.46M 0.08% 293
2022
Q4 		$1.48M Buy
+19,933
New +$1.36M 0.02% 775
2021
Q4 		– Sell
-7,228
Closed -$554K – 2325
2021
Q3 		$554K Sell
7,228
-7,831
-52% -$629K 0.01% 1321
2021
Q2 		$1.17M Buy
15,059
+8,400
+126% +$597K 0.01% 922
2021
Q1 		$411K Sell
6,659
-390
-6% -$24.7K 0.01% 1489
2020
Q4 		$460K Sell
7,049
-23,890
-77% -$1.37M ﹤0.01% 1305
2020
Q3 		$1.53M Buy
30,939
+12,159
+65% +$627K 0.03% 494
2020
Q2 		$896K Buy
+18,780
New +$906K 0.02% 799
2020
Q1 		– Sell
-39,029
Closed -$2.3M – 1286
2019
Q4 		$2.3M Buy
+39,029
New +$2.12M 0.04% 311
2019
Q1 		– Sell
-5,605
Closed -$243K – 706
2018
Q4 		$243K Buy
+5,605
New +$280K 0.02% 229

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Michael Gelband's GMED Position: Q2 2026 in Review

Michael Gelband sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 208,902 shares — an estimated $18M sold.

Michael Gelband first reported a position in GMED in Q4 2018 and held it in 17 quarters. The position peaked at $40.6M in Q3 2024. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Michael Gelband reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 208,902 Globus Medical shares in Q2 2026, an estimated $18M.
  • Michael Gelband first reported a position in Globus Medical in Q4 2018 and held it in 17 quarters.
  • Michael Gelband's Globus Medical position peaked at $40.6M in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.